<VariationArchive VariationID="7651" VariationName="NM_000538.4(RFXAP):c.368del (p.Ser123fs)" VariationType="Deletion" Accession="VCV000007651" Version="6" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-07-29" DateCreated="2013-04-04" MostRecentSubmission="2024-06-02">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="22690" VariationID="7651">
      <GeneList>
        <Gene Symbol="RFXAP" FullName="regulatory factor X associated protein" GeneID="5994" HGNC_ID="HGNC:9988" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>13q13.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="13" Accession="NC_000013.11" start="36819222" stop="36829104" display_start="36819222" display_stop="36829104" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="13" Accession="NC_000013.10" start="37393338" stop="37403739" display_start="37393338" display_stop="37403739" Strand="+" />
          </Location>
          <OMIM>601861</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000538.4(RFXAP):c.368del (p.Ser123fs)</Name>
      <CanonicalSPDI>NC_000013.11:36819724:G:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>13q13.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="13" Accession="NC_000013.11" start="36819725" stop="36819725" display_start="36819725" display_stop="36819725" variantLength="1" positionVCF="36819724" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="13" Accession="NC_000013.10" start="37393862" stop="37393862" display_start="37393862" display_stop="37393862" variantLength="1" positionVCF="37393861" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>S123fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000013.10" sequenceAccession="NC_000013" sequenceVersion="10" change="g.37393862del" Assembly="GRCh37">
            <Expression>NC_000013.10:g.37393862del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000013.11" sequenceAccession="NC_000013" sequenceVersion="11" change="g.36819725del" Assembly="GRCh38">
            <Expression>NC_000013.11:g.36819725del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007876.1" sequenceAccession="NG_007876" sequenceVersion="1" change="g.5524del">
            <Expression>NG_007876.1:g.5524del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000538.3" sequenceAccession="NM_000538" sequenceVersion="3" change="c.368delG">
            <Expression>NM_000538.3:c.368delG</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000529.1" sequenceAccession="NP_000529" sequenceVersion="1" change="p.Ser123Thrfs">
            <Expression>NP_000529.1:p.Ser123Thrfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000538.4" sequenceAccession="NM_000538" sequenceVersion="4" change="c.368del" MANESelect="true">
            <Expression>NM_000538.4:c.368del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000529.1" sequenceAccession="NP_000529" sequenceVersion="1" change="p.Ser123fs">
            <Expression>NP_000529.1:p.Ser123fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_103" sequenceAccession="LRG_103">
            <Expression>LRG_103:g.5524del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_103t1" sequenceAccession="LRG_103t1">
            <Expression>LRG_103t1:c.368del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="601861.0003" DB="OMIM" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff provided HGVS expressions for allelic variant 601861.0003 from the sequence reported in Figure 7A of the paper by Durand et al., 1997 (PubMed 9118943).</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000538.4(RFXAP):c.368del (p.Ser123fs) AND MHC class II deficiency" Accession="RCV002512887" Version="2">
        <ClassifiedConditionList TraitSetID="6425">
          <ClassifiedCondition DB="MedGen" ID="C2931418">MHC class II deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-07-17" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000538.4(RFXAP):c.368del (p.Ser123fs) AND MHC class II deficiency 4" Accession="RCV004576886" Version="1">
        <ClassifiedConditionList TraitSetID="2087">
          <ClassifiedCondition DB="MedGen" ID="C1859537">MHC class II deficiency 4</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1997-09-11" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-07-17" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2013-04-04" MostRecentSubmission="2024-06-02">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">20197681</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22390233</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">650344</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">7021490</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9118943</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9287230</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="6425" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="486" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">MHC class II deficiency</ElementValue>
                <XRef ID="MONDO:0008855" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Bare lymphocyte syndrome 2</ElementValue>
                <XRef ID="C537079" DB="MeSH" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">BLS 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Severe combined immunodeficiency, HLA class II negative</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">SCID, HLA Class 2-Negative</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">SCID, HLA CLASS II-NEGATIVE</ElementValue>
                <XRef Type="MIM" ID="209920" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">BARE LYMPHOCYTE SYNDROME, TYPE II, COMPLEMENTATION GROUP A</ElementValue>
                <XRef Type="MIM" ID="209920" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">BLS, TYPE II</ElementValue>
                <XRef Type="MIM" ID="209920" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Bare Lymphocyte Syndrome</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="824" />
                <XRef ID="824" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="572" DB="Orphanet" />
              <XRef ID="C2931418" DB="MedGen" />
              <XRef ID="MONDO:0008855" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS209920" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="2087" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="8787" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">MHC class II deficiency 4</ElementValue>
                <XRef ID="MONDO:0971015" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MHC2D4</ElementValue>
                <XRef Type="MIM" ID="620817" DB="OMIM" />
              </Symbol>
              <XRef ID="C1859537" DB="MedGen" />
              <XRef ID="MONDO:0971015" DB="MONDO" />
              <XRef Type="MIM" ID="620817" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="28295" SubmissionDate="2020-03-31" DateLastUpdated="2024-06-02" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="601861.0003_MHC CLASS II DEFICIENCY 4" title="RFXAP, 1-BP DEL, 484G_MHC CLASS II DEFICIENCY 4" />
        <ClinVarAccession Accession="SCV000028295" DateUpdated="2024-06-02" DateCreated="2013-04-04" Type="SCV" Version="4" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1997-09-11">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In an EBV-transformed B-cell line established from a patient (DA), born of consanguineous Algerian parents, with MHC class II deficiency-4 (MHC2D4; 620817), Durand et al. (1997) identified a homozygous 1-bp deletion (c.484delG) in the RFXAP gene, resulting in a frameshift and premature termination that would result in an inactive protein of only 136 amino acids. The parents of DA were not available for study, but they were stated to have been first cousins. The patient belonged to one of the first families with MHC class II deficiency described (Touraine et al., 1978; Touraine and Betuel, 1981). Durand et al. (1997) found that transfection of patient cells with RFXAP cDNA restored a normal MHC class II positive phenotype. Cell surface expression of the 3 MHC class II isotypes was restored to wildtype levels, indicating that the alpha and beta chain genes for HLA-DR, -DP, and -DQ were all reactivated coordinately.</Attribute>
              <Citation>
                <ID Source="PubMed">9118943</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">7021490</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">650344</ID>
              </Citation>
              <XRef DB="OMIM" ID="620817" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Villard et al. (1997) found this same mutation in a patient with MHC2D4.</Attribute>
              <Citation>
                <ID Source="PubMed">9287230</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RFXAP" />
          </GeneList>
          <Name>RFXAP, 1-BP DEL, 484G</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 484G</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="601861.0003" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">MHC CLASS II DEFICIENCY 4</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="6130946" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="4913756|MedGen:C2931418" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003442071" DateUpdated="2024-02-14" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-07-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9118943</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22390233</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9118943</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20197681</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Ser123Thrfs*15) in the RFXAP gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RFXAP are known to be pathogenic (PMID: 9118943, 22390233). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with MHC class II deficiency (PMID: 9118943, 20197681). This variant is also known as deletion of a G residue at nucleotide 484. ClinVar contains an entry for this variant (Variation ID: 7651). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RFXAP" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000013.10:g.37393862del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C2931418" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="28295" TraitType="Disease" MappingType="Name" MappingValue="MHC CLASS II DEFICIENCY 4" MappingRef="Preferred">
        <MedGen CUI="C1859537" Name="MHC class II deficiency 4" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6130946" TraitType="Disease" MappingType="XRef" MappingValue="C2931418" MappingRef="MedGen">
        <MedGen CUI="C2931418" Name="MHC class II deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

